Jablons DM - Search Results

1

Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.

Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, Jablons DM. Xia C, et al. Among authors: jablons dm. Mol Cancer Ther. 2002 Jul;1(9):687-94. Mol Cancer Ther. 2002. PMID: 12479365

2

ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.

You L, Yang CT, Jablons DM. You L, et al. Among authors: jablons dm. Cancer Res. 2000 Feb 15;60(4):1009-13. Cancer Res. 2000. PMID: 10706117

3

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.

Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, Jablons DM. Yang CT, et al. Among authors: jablons dm. J Natl Cancer Inst. 2000 Apr 19;92(8):636-41. doi: 10.1093/jnci/92.8.636. J Natl Cancer Inst. 2000. PMID: 10772681

4

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.

Casibang M, Purdom S, Jakowlew S, Neckers L, Zia F, Ben-Av P, Hla T, You L, Jablons DM, Moody TW. Casibang M, et al. Among authors: jablons dm. Lung Cancer. 2001 Feb-Mar;31(2-3):203-12. doi: 10.1016/s0169-5002(00)00168-9. Lung Cancer. 2001. PMID: 11165399

5

Expression sequence tag-specific full-length cDNA cloning: actin cDNAs.

Xu Z, Jablons DM, Gruenert DC. Xu Z, et al. Among authors: jablons dm. Gene. 2001 Jan 24;263(1-2):265-72. doi: 10.1016/s0378-1119(00)00559-x. Gene. 2001. PMID: 11223266

6

Stage II (N1) lung cancer.

Choy O, Jahan T, Roach M 3rd, You L, Jablons D. Choy O, et al. Chest Surg Clin N Am. 2001 Feb;11(1):39-59, viii. Chest Surg Clin N Am. 2001. PMID: 11253600 Review.

7

p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.

Yang CT, You L, Uematsu K, Yeh CC, McCormick F, Jablons DM. Yang CT, et al. Among authors: jablons dm. Cancer Res. 2001 Aug 15;61(16):5959-63. Cancer Res. 2001. PMID: 11507034

8

Cloning and characterization of a functional promoter of the human SOCS-3 gene.

He B, You L, Uematsu K, Matsangou M, Xu Z, He M, McCormick F, Jablons DM. He B, et al. Among authors: jablons dm. Biochem Biophys Res Commun. 2003 Feb 7;301(2):386-91. doi: 10.1016/s0006-291x(02)03071-1. Biochem Biophys Res Commun. 2003. PMID: 12565872

9

A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.

Yang CT, You L, Lin YC, Lin CL, Mccormick F, Jablons DM. Yang CT, et al. Among authors: jablons dm. Anticancer Res. 2003 Jan-Feb;23(1A):33-8. Anticancer Res. 2003. PMID: 12680192

10

Malignant mesothelioma does not demonstrate overexpression or gene amplification despite cytoplasmic immunohistochemical staining for c-Erb-B2.

Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA. Horvai AE, et al. Among authors: jablons dm. Arch Pathol Lab Med. 2003 Apr;127(4):465-9. doi: 10.5858/2003-127-0465-MMDNDO. Arch Pathol Lab Med. 2003. PMID: 12683876 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters